PATENT CLAIM ANALYSIS

Application Number: 16234809
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-10
Patent Classification: ["544", "271000"]

Abstract:
The present invention relates to pharmaceutical compounds of the Formula (I), or a pharmaceutically acceptable salt or composition thereof, and methods of their use for the treatment of pain, respiratory conditions, as well as inhibiting the Transient Receptor Potential A1 ion channel (TRPA1).

Claim (Index 34):
A method of treating chronic pain in a subject comprising administering an effective amount of a compound according to  claim 26 , or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 54.0
- Percentile: 98.0
- Lexical Diversity: 1.26829
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15940253', '15512213', '14160333', '14903475', '11954799']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.727552664301827
- 35 USC 102 Novelty (BERT): 0.5240604053011416
- Combined Prediction Score: 0.7072034384017585
- Mean Citation Score: 276.061584
- Max Citation Score: 329.07544
- Similarity Product: 250.32795766737945

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test